Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Laruelle

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Current Opinion in Pharmacology|February 15, 2014
Schizophrenia: from dopaminergic to glutamatergic interventionsMarc Laruelle
Annals of Nuclear Medicine|January 2, 2003
Neuroreceptor imaging in psychiatric disordersW Gordon Frankle, Marc Laruelle
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 7, 2002
The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug developmentPeter S Talbot, Marc Laruelle
European Psychiatry : the Journal of the Association of European Psychiatrists|January 12, 2005
Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studiesAnissa Abi-Dargham, Marc Laruelle
Methods (San Diego, Calif.)|August 17, 2002
Positron emission tomography: imaging and quantification of neurotransporter availabilityMarc Laruelle, Mark Slifstein, Yiyun Huang
Molecular Imaging and Biology|December 12, 2003
Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomographyMarc Laruelle, Mark Slifstein, Yiyun Huang
Bioconjugate Chemistry|January 20, 2005
Positron-labeled dopamine agonists for probing the high affinity states of dopamine subtype 2 receptorsDah-Ren Hwang, Raj Narendran, Marc Laruelle
International Review of Neurobiology|March 14, 2007
Neurobiology of dopamine in schizophreniaOlivier Guillin, Anissa Abi-Dargham, Marc Laruelle
Bioorganic & Medicinal Chemistry Letters|July 26, 2005
Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptorsYiyun Huang, Zhihong Zhu, Yingxian Xiao, et al.
Annals of the New York Academy of Sciences|December 20, 2003
Glutamate, dopamine, and schizophrenia: from pathophysiology to treatmentMarc Laruelle, Lawrence S Kegeles, Anissa Abi-Dargham
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Current Opinion in Pharmacology|February 15, 2014
Schizophrenia: from dopaminergic to glutamatergic interventionsMarc Laruelle
Annals of Nuclear Medicine|January 2, 2003
Neuroreceptor imaging in psychiatric disordersW Gordon Frankle, Marc Laruelle
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 7, 2002
The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug developmentPeter S Talbot, Marc Laruelle
European Psychiatry : the Journal of the Association of European Psychiatrists|January 12, 2005
Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studiesAnissa Abi-Dargham, Marc Laruelle
Methods (San Diego, Calif.)|August 17, 2002
Positron emission tomography: imaging and quantification of neurotransporter availabilityMarc Laruelle, Mark Slifstein, Yiyun Huang
Molecular Imaging and Biology|December 12, 2003
Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomographyMarc Laruelle, Mark Slifstein, Yiyun Huang
Bioconjugate Chemistry|January 20, 2005
Positron-labeled dopamine agonists for probing the high affinity states of dopamine subtype 2 receptorsDah-Ren Hwang, Raj Narendran, Marc Laruelle
International Review of Neurobiology|March 14, 2007
Neurobiology of dopamine in schizophreniaOlivier Guillin, Anissa Abi-Dargham, Marc Laruelle
Bioorganic & Medicinal Chemistry Letters|July 26, 2005
Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptorsYiyun Huang, Zhihong Zhu, Yingxian Xiao, et al.
Annals of the New York Academy of Sciences|December 20, 2003
Glutamate, dopamine, and schizophrenia: from pathophysiology to treatmentMarc Laruelle, Lawrence S Kegeles, Anissa Abi-Dargham
Pageof 11